About Vimian Group AB 
Vimian Group AB
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1,241 Million
(Quarterly Results - Mar 2026)
Net Profit:
108 Million
Pharmaceuticals & Biotechnology
SEK 16,384 Million (Small Cap)
30.00
NA
0.00%
0.26
6.39%
2.07






